Yalan Yu

581 total citations
22 papers, 417 citations indexed

About

Yalan Yu is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Yalan Yu has authored 22 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Hematology. Recurrent topics in Yalan Yu's work include MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers) and Circular RNAs in diseases (4 papers). Yalan Yu is often cited by papers focused on MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers) and Circular RNAs in diseases (4 papers). Yalan Yu collaborates with scholars based in China and United States. Yalan Yu's co-authors include Jiancheng Tu, Xuelan Zuo, Sanyun Wu, Ping Luo, Shuo Li, Xinliang Ming, Mingxia Yu, Chunzi Liang, Qian Tan and Man Zhu and has published in prestigious journals such as Journal of Visualized Experiments, International Journal of Oncology and Journal of Immunology Research.

In The Last Decade

Yalan Yu

20 papers receiving 410 citations

Peers

Countries citing papers authored by Yalan Yu

Since Specialization

Citations

This map shows the geographic impact of Yalan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yalan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yalan Yu more than expected).

Fields of papers citing papers by Yalan Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yalan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yalan Yu. The network helps show where Yalan Yu may publish in the future.

Co-authorship network of co-authors of Yalan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yalan Yu. A scholar is included among the top collaborators of Yalan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yalan Yu. Yalan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Combination of JAK2V617F Allele Burden and WT1 Expression can Be Helpful in Distinguishing the Subtype of MPN Patients 2023 ·Cancer Control ·Sanyun Wu, Ping Luo, (unknown), Yalan Yu, Bei Xiong, (unknown), Xuelan Zuo	1
2	Detection and quantification of JAK2V617F copy number by droplet digital PCR versus real-time PCR 2023 ·Annals of Hematology ·(unknown), Yixuan Li, (unknown), (unknown), Yalan Yu, Ping Luo, Xuelan Zuo, Li He	1
3	EDTA plasma in glass and polyethylene terephthalate tubes is suitable for measurement of B-type natriuretic peptide on the Mindray CL-6000i 2023 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·Wei Zhao, Gang Feng, Jun Wan, Xing Wang, (unknown), Wanwan Zhang, Yalan Yu, Rui Pu, Yong Du, (unknown)	0
4	Extracellular Volume Fraction Based on Cardiac Magnetic Resonance T1 Mapping: An Effective Way to Evaluate Cardiac Injury Caused by Cardiac Amyloidosis in Patients with Multiple Myeloma 2022 ·Journal of Immunology Research ·(unknown), Liang Shao, (unknown), Qian Wang, Balu Wu, Xiaoyan Liu, Yalan Yu, Tingting Huang, (unknown), Yong He, (unknown), Fuling Zhou	1
5	Application of super-resolution fluorescence microscopy in hematologic malignancies 2022 ·Journal of Innovative Optical Health Sciences ·Yalan Yu, Jianing Yu, Zhen‐Li Huang, Fuling Zhou	5
6	Interphase Fluorescence <em>in situ</em> Hybridization of Bone Marrow Smears of Multiple Myeloma 2022 ·Journal of Visualized Experiments ·Yalan Yu, Hui Shen, Li Liu, (unknown), Sanyun Wu, Jing He, (unknown), Yufeng Shang, Liang Shao, Fuling Zhou	1
7	Adversarial Multiscale Feature Learning Framework for Overlapping Chromosome Segmentation 2022 ·Entropy ·Liye Mei, Yalan Yu, Hui Shen, (unknown), (unknown), Du Wang, Sheng Liu, Fuling Zhou, Cheng Lei	15
8	High-throughput and high-accuracy diagnosis of multiple myeloma with multi-object detection 2022 ·Biomedical Optics Express ·Liye Mei, Hui Shen, Yalan Yu, (unknown), Xiaoxiao Li, Kashif Rafiq Zahid, Jin Huang, Du Wang, Sheng Liu, Fuling Zhou, Cheng Lei	6
9	Reduced miR-16 levels are associated with VEGF upregulation in high-risk myelodysplastic syndromes 2021 ·Journal of Cancer ·Bei Xiong, (unknown), Yalan Yu, Shixuan Wang, Xuelan Zuo	2
10	A new workflow on bone marrow aspiration and biopsy during the COVID-19 pandemic 2021 ·Archives of Medical Science ·Hui Xiao, Jing He, Sanyun Wu, Hui Shen, (unknown), Xiaoyan Liu, Yalan Yu, Tingting Huang, Ping Luo, Fuling Zhou	0
11	The effect of miR-223 on cellular behaviour in non-5q myelodysplastic syndromes through targeting RPS14 2020 ·Pathology ·(unknown), Shixuan Wang, Yalan Yu, Xuelan Zuo, Bei Xiong	3
12	SF3B1 Mutation but Not Ring Sideroblasts Identifies a Specific Group of Myelodysplastic Syndrome–Refractory Cytopenia With Multilineage Dysplasia 2020 ·Clinical Lymphoma Myeloma & Leukemia ·Bei Xiong, Mei Xue, Yalan Yu, Sanyun Wu, Xuelan Zuo	5
13	Novel Insights Into Illness Progression and Risk Profiles for Mortality in Non-survivors of COVID-19 2020 ·Frontiers in Medicine ·Liang Shao, Xinyi Li, Yi Zhou, Yalan Yu, Yanan Liu, (unknown), Ruixian Zhang, Haojian Zhang, Xinghuan Wang, Fuling Zhou	17
14	Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage 2019 ·Pathology & Oncology Research ·Ping Luo, Sanyun Wu, Yalan Yu, Xinliang Ming, Shuo Li, Xuelan Zuo, Jiancheng Tu	159
15	Fluorescence in�situ hybridization comparison of the prognostic factors in adult and pediatric acute lymphoblastic leukemia: A retrospective analysis of 282�cases 2018 ·Experimental and Therapeutic Medicine ·Pengfei Cao, Yalan Yu, Wei Wang, He Xu, Yuxiang He	2
16	Xingnao Kaiqiao acupuncture combined with Angong Niuhuang Wan for a patient under persistent vegetative state: a case report 2017 ·Frontiers of Medicine ·(unknown), Chen Xiao, Yalan Yu, Ling Zhang	14
17	Identification of long non-coding RNA 00312 and 00673 in human NSCLC tissues 2017 ·Molecular Medicine Reports ·Qian Tan, Yalan Yu, Nandi Li, Jing Wei, Hu Zhou, Shili Qiu, Chunzi Liang, Mingxia Yu, Jiancheng Tu	15
18	Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosis 2017 ·International Journal of Oncology ·Qian Tan, (unknown), Shili Qiu, Yalan Yu, Hu Zhou, Nandi Li, Hui Wang, Chunzi Liang, Mingxia Yu, Jiancheng Tu	50
19	Plasma miR-92a-2 as a biomarker for small cell lung cancer 2017 ·Cancer Biomarkers ·Yalan Yu, (unknown), Qian Tan, (unknown), Ping Li, Man Zhu, Mingxia Yu, Zhenming Fu, Chunzi Liang, Jiancheng Tu	34
20	Inhibition of miR-155, a therapeutic target for breast cancer, prevented in cancer stem cell formation 2017 ·Cancer Biomarkers ·(unknown), Yalan Yu, Man Zhu, Jing Wei, Mingxia Yu, Hongyan Chai, Chunzi Liang, (unknown)	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact